financetom
Business
financetom
/
Business
/
Alphabet's Google Loses Appeal in Epic Games' Antitrust Lawsuit
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Alphabet's Google Loses Appeal in Epic Games' Antitrust Lawsuit
Jul 31, 2025 11:45 AM

02:13 PM EDT, 07/31/2025 (MT Newswires) -- Alphabet's (GOOG, GOOGL) Google ( GOOG ) lost its appeal to overturn a jury verdict and federal court order in an antitrust lawsuit filed by Epic Games, according to a ruling Thursday by the US Court of Appeals for the Ninth Circuit.

The court rejected Google's ( GOOG ) claim that a decision favoring Apple in a lawsuit filed by Epic precludes Epic from defining the market differently in this case. The court also said the district court did not abuse its discretion in allowing a jury trial.

"We affirm the district court's injunction, which was supported by the jury's verdict as well as the district court's own findings," the court said.

Epic won the jury case in San Francisco in 2023, and in October 2024, US District Judge James Donato ordered Google ( GOOG ) to restore competition by allowing users to download other app stores in October 2024, according to the document.

Google ( GOOG ) filed an appeal with the court, which then rejected the company's claims that the trial judge made legal errors in the antitrust case, the document said.

Microsoft ( MSFT ) , the Justice Department, and Federal Trade Commission filed briefs supporting Epic, according to the document.

"This decision will significantly harm user safety, limit choice, and undermine the innovation that has always been central to the Android ecosystem," Google's ( GOOG ) global head of regulatory affairs Lee-Anne Mulholland said in an emailed statement to MT Newswires. "Our top priority remains protecting our users, developers and partners, and maintaining a secure platform as we continue our appeal."

Price: 193.36, Change: -4.08, Percent Change: -2.07

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Former FDA vaccine chief Peter Marks joins Eli Lilly
Former FDA vaccine chief Peter Marks joins Eli Lilly
Oct 7, 2025
(Reuters) -Peter Marks, the former top vaccine regulator who was ousted from the U.S. Food and Drug Administration earlier this year, has joined Eli Lilly ( LLY ), the drugmaker told Reuters on Tuesday. Marks will oversee molecule discovery and infectious diseases at Lilly Research Laboratories. Peter's expertise strengthens our abilities across multiple areas, both in our existing portfolio and...
Sector Update: Consumer
Sector Update: Consumer
Oct 7, 2025
03:15 PM EDT, 10/07/2025 (MT Newswires) -- Consumer stocks were mixed late Tuesday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) increasing 0.6% and the Consumer Discretionary Select Sector SPDR Fund (XLY) retreating 1.7%. Redbook US same-store sales rose by 5.8% from a year earlier in the week ended Oct. 4 after a 5.9% year-over-year increase in the...
ExchangeRight All-Cash 14 DST Fully Subscribed, Expanding Essential Income REIT Pipeline
ExchangeRight All-Cash 14 DST Fully Subscribed, Expanding Essential Income REIT Pipeline
Oct 7, 2025
PASADENA, Calif.--(BUSINESS WIRE)-- ExchangeRight has announced the full subscription of Net-Leased All-Cash 14 DST, adding to the growing acquisition pipeline for ExchangeRight’s Essential Income REIT. The $23.3 million debt-free portfolio of net-leased real estate, backed by tenants operating in necessity-based industries, provides investors with monthly distributions at a current rate of 5.20% covered entirely by in-place lease revenues. Net-Leased All-Cash...
Former FDA vaccine chief Peter Marks joins Eli Lilly
Former FDA vaccine chief Peter Marks joins Eli Lilly
Oct 7, 2025
Oct 7 (Reuters) - Peter Marks, the former top vaccine regulator who was ousted from the U.S. Food and Drug Administration earlier this year, has joined Eli Lilly ( LLY ), the drugmaker told Reuters on Tuesday. Marks will oversee molecule discovery and infectious diseases at Lilly Research Laboratories. Peter's expertise strengthens our abilities across multiple areas, both in our...
Copyright 2023-2026 - www.financetom.com All Rights Reserved